Octagon Capital Advisors’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-273,289
| Closed | -$8.83M | – | 51 |
|
|
2024
Q1 | $8.83M | Hold |
273,289
| – | – | 1.06% | 26 |
|
|
2023
Q4 | $11.5M | Buy |
+273,289
| New | +$11.5M | 1.84% | 14 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 38 |
|
|
2022
Q4 | – | Sell |
-579,061
| Closed | -$3.23M | – | 41 |
|
|
2022
Q3 | $3.23M | Hold |
579,061
| – | – | 0.56% | 26 |
|
|
2022
Q2 | $2.26M | Sell |
579,061
-895,939
| -61% | -$3.49M | 0.6% | 16 |
|
|
2022
Q1 | $8.13M | Buy |
1,475,000
+902,138
| +157% | +$4.97M | 1.76% | 16 |
|
|
2021
Q4 | $4.88M | Buy |
+572,862
| New | +$4.88M | 0.95% | 20 |
|